Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.33EBITDA per Share
VS
Market
Sector
Industry
History
$ 1.29Close
$ 0.73 - $ 1.49 52-Week Range
Ticker Information
Ticker
ESLACompany Name
ESTRELLA IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQESTRELLA IMMUNOPHARMA INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESLA - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -12.08M | $ -0.33 | 1 | 36.17M |
| 3/31/2025 | $ -10.48M | $ -0.29 | 1 | 36.19M |
| 12/31/2024 | $ -8.85M | $ -0.24 | 1 | 36.82M |
| 9/30/2024 | $ -8.82M | $ -0.24 | 1 | 36.21M |
| 6/30/2024 | $ -7.31M | $ -0.27 | 1 | 27.1M |
| 3/31/2024 | $ -6.11M | $ -0.17 | 1 | 35.52M |
| 12/31/2023 | $ -8.36M | $ -0.24 | 1 | 35.2M |
| 9/30/2023 | $ -7.41M | $ -7.04 | 1 | 1.05M |
| 6/30/2023 | $ -11.11M | $ -8.75 | 1 | 1.27M |
| 3/31/2023 | $ -818.06K | $ -0.35 | 1 | 2.33M |
Key Performance Insights, Last 5 Years
- ESTRELLA IMMUNOPHARMA INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
- Over the past 5 years, ESTRELLA IMMUNOPHARMA INC's average EBITDAPS has been $ -1.32.
- The median EBITDAPS for ESTRELLA IMMUNOPHARMA INC during this period was $ -0.24
- ESTRELLA IMMUNOPHARMA INC reached its highest EBITDAPS over the past 5 years at $ -0.08.
- The lowest EBITDAPS recorded by ESTRELLA IMMUNOPHARMA INC in the same timeframe $ -8.75
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ESTRELLA IMMUNOPHARMA INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 1M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ] ESLA - EBITDA per Share, Last 5 years
$ -8.75
Minimum
Jun 30, 2023
$ -0.08
Maximum
Dec 31, 2021
$ -1.32
Average
$ -0.24
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |